TipRanks
Bicycle Therapeutics Ltd (DE:50BA)
FRANKFURT:50BA

Compare Bicycle Therapeutics (50BA) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Bicycle Therapeutics
€3.46
€242.38M
-1.42
-52.17%
3 Buy
3 Hold
0 Sell
Moderate Buy
MacroGenics
$4.04
$238.24M
-17.05
113.71%
2 Buy
2 Hold
0 Sell
Moderate Buy
Sutro Biopharma
$21.43
$236.61M
-0.83
66.90%
7 Buy
0 Hold
1 Sell
Strong Buy
ADC Therapeutics
$1.05
$220.87M
-2.61
-62.31%
1 Buy
1 Hold
0 Sell
Moderate Buy
Molecular Partners
$4.45
$156.21M
-2.36
1.58%
2 Buy
0 Hold
0 Sell
Moderate Buy
Pyxis Oncology
$3.06
$242.50M
-1.44
-47.00%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:50BA
Bicycle Therapeutics
3.30
-3.80
-53.52%
MGNX
MacroGenics
3.74
2.10
128.05%
STRO
Sutro Biopharma
14.27
5.99
72.26%
ADCT
ADC Therapeutics
1.73
-2.88
-62.47%
MOLN
Molecular Partners
3.85
0.06
1.58%
PYXS
Pyxis Oncology
2.03
-1.42
-41.16%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts